News and Events
Global Fund Prospective Country Evaluation: Uganda 2018 Annual Report
This brief presents findings from the Global Fund Prospective Country Evaluation (PCE) in Uganda assessing the role
and function of partnerships in the 2017 Global Fund application process. It was prepared by the Infectious Diseases
Research Collaboration (IDRC), Uganda, and PATH, USA, in collaboration with the Institute for Health Metrics and
Evaluation (IHME) at the University of Washington, USA.
Download The Report.
Global Fund Prospective Country Evaluation: Uganda 2018 Annual Report
The Prospective Country Evaluation (PCE) is an independent evaluation of the Global Fund commissioned by the Global Fund’s Technical Evaluation Reference Group (TERG). The PCE is designed to evaluate how Global Fund policies and processes play out in country in real time and provide high quality, actionable, timely information to national program implementers and Global Fund. This report provides an overview of setting up the PCE platform in Uganda, progress to-date and highlights early findings from the initial evaluation phase covering October 2017 – February 2018, which focused on the funding request and grant-making process for Global Fund’s 2017-2019 application cycle.
Download The Report.
The Global Fund Prospective Country Evaluation: Uganda Report on Partnership in the Global Fund Application Cycle
On Friday 27th April, the PCE disseminated its findings for the initial evaluation phase covering October 2017 – February 2018, which focused on the funding request and grant-making process for Global Fund’s 2017-2019 application cycle.
The Prospective Country Evaluation (PCE) is an independent evaluation of the Global Fund commissioned by the Global Fund’s Technical Evaluation Reference Group (TERG). The PCE is designed to evaluate how Global Fund policies and processes play out in country in real time and provide high quality, actionable, timely information to national program implementers and Global Fund. The first six months of the PCE drew upon process evaluation methods utilizing multiple data sources including Key Informant Interviews (KIIs), process tracking, document review, and non-participant observation of various meetings.
The Global Fund Business Model in Practice in Uganda.
The 2017-2019 funding request and grant-making process was perceived as largely transparent and inclusive as well as better coordinated and managed compared to previous application cycles. Over time, the country has amassed significant capacity, experience, and expertise to develop well-aligned, strong funding requests that meet Global Fund requirements with minimum or no support from foreign expatriates. Clear guidance and a stated resource envelope also facilitated the application process, although the grant making process was perceived unclear as stakeholders were not sure who should be have participated in the grant making process and what exactly is discussed during this process.
Translation of Global Fund Strategy and Policy in Uganda.
The 2017-2022 strategy focused on addressing resilient and sustainable systems for health (RSSH), key and vulnerable populations, gender and human rights, and how the sustainability, transition, and co-financing (STC) policy translates at country level. Generally, there was strong participation of key and vulnerable populations, and gender and human rights constituencies in the 2017-2019 funding request development compared to the previous funding cycle. Based on Global Fund requirements for co-financing, the country demonstrated the needed commitment to meet the counterpart funding for the three disease programs. However, there was unclear guidance regarding RSSH and catalytic components of the funding request.
There is an opportunity to provide explicit guidelines about RSSH and address concerns with implementing these activities.
The Global Fund’s new funding model is progressively streamlining and differentiating grant application and approval processes in-line with the country context. This contributed to timely submission of funding requests with the aim of limiting significant delays into the implementation period. The successes of the 2017-2019 funding cycle were likely achieved through a combination of: (1) changes to grant development process; (2) a strong and supportive Country Team, which helped advise and kept the funding request and grant-making on track; and (3) overall better country preparedness (in terms of gathering the necessary evidence) as well as experience and capacity of in-country stakeholders for Global Fund processes. To further maximize the impact of Global Fund efforts against malaria, HIV and TB, there is need for harmonizing Global Fund policy documents so that they are better aligned with the countries policies and priorities.
IDRC exhibition tent on world malaria day, 25th April 2018 in Mpigi Uganda. A special thank you to all who visted our tent.
ClinEpiDB is live!!! New Open-access Data Resource Aims to Bolster Collaboration in Global Infectious Disease Research. https://clinepidb.org
The website presents data from the Program for Resistance, Immunology, Surveillance and modelling of Malaria (PRISM) led by Grant Dorsey, professor of Medicine at the University of California, San Francisco and Moses Kamya,
Professor and Dean, school of medicine, Makerere University College of Health Sciences, Kampala Uganda. PRISM is one of the several International Centres of Excellence for Malaria research funded by NIH and presents 1400 participants
from 331 households from three regions in Uganda (Jinja, Kanungu and Tororo) with more than 44000 clinical observations.
It introduces a web based interface that allows users to explore data using point and click filtering, simple queries, more complex search strategies and a suit of shinny analysis tools that allows for further exploration of the data.
Prof Kamya selected as one of UC Berkeley, the School of Public Health's 75 Influential Alumni
Prof Moses Kamya has been selected by UC Berkeley, School of Public Health to be honored as one of their 75 most influential public health alumni over our entire 75-year history. UC Berkeley will be formally honouring Prof. Kamya during their 75th Anniversary celebration in April 2018. Since 1943, the UC Berkeley School of Public Health has been fortunate to attract bright, motivated students who go on to make notable contributions to the health of our communities, in California and around the world. Prof. Kamya was nominated and selected for his contributions and achievements that serve as a source of inspiration to UC Berkeley’s public health community. The management and staff of IDRC join hands to congratulate Prof. Kamya
The 10th East Africa Collaborative Scientific Symposium
The 10th East Africa Collaborative Scientific Symposium is taking place on January th, 2018 in Kampala, Uganda. The two-day meeting will feature presentations on innovative research projects and a research workshop. Follow the links to register or submit an abstract.
The 6th Annual MU-UCSF-LSMTH Young Investigator Research Symposium
The 6th Annual MU-UCSF-LSMTH Young Investigator Research Symposium is taking place on January 17th and 18th, 2018 in Kampala, Uganda. This symposium is expected to bring together young and senior researchers in the fields of Malaria, Community Interventions, Tuberculosis, HIV/AIDS, Pre-term birth/pediatrics, and immunology/laboratory research. We will have presentations of abstracts, discussions, awards for stellar performance amongst other activities. Please register for the symposium here
IDRC to carry out Prospective Country Evaluation
IDRC in collaboration with Institute for Health Metrics and Evaluation (IHME) has been awarded Prospective Country Evaluation (PCE) for Uganda for 3 years (2017 - 2020). The PCE is a comprehensive, country-level, prospective evaluation that utilize a variety of methods to provide a detailed, real-time picture of the implementation, effectiveness and impact of Global Fund-supported programmes in selected countries. The goal of PCE is to generate evidence on program implementation through impact to accelerate progress towards strategic objectives of the Global Fund Strategy and to facilitate continuous improvement of program implementation and quality.
PRISM Project renewed for 7 years
We would like to congratulate Professors Grant Dorsey (University of California San Francisco) and Moses Kamya (Makerere University/IDRC) for the award from the NIAID for an International Center for Excellence in Malaria Research (ICEMR)! The Program for Resistance, Immunology, Surveillance and Modeling of Malaria in Uganda (PRISM) has received a 7-year grant (up to 2024) at around $1 million annually.
PRISM is one of seven ICEMR programs selected worldwide in malaria-endemic settings. The first seven-year ICEMR award/PRISM project 2010-2017 was also funded by NIAID and we are pleased to receive another grant award from NIAID. The PRISM project is based in Eastern Uganda and its goals are to perform surveillance of malaria in order to improve understanding and to measure the impact of population-level control interventions.
NIH press release: https://www.nih.gov/news-events/news-releases/nih-funds-seven-international-centers-excellence-malaria-research
IDRC exhibition tent on world malaria day, 25th April 2017 in Fort Portal Uganda. A special thank you to all who visted our tent.
MIND study celebrates 10 years
10 years ago (March 28, 2007), the MIND Study enrolled the first participant.
Now, more than 4,400 subjects have been enrolled, we have obtained more than $13,949,000 in NIH grants, and we have authored 41 scholarly publications
(with an additional 7 manuscripts currently under peer-review).
As important – and perhaps more importantly – the study has built enduring clinical capacity (Bronchoscopy Suites at Mulago and now at Naguru) and provided
important clinical services (clinical bronchoscopy at 2 hospitals, the first GeneXpert machine at Mulago Hospital, capability to diagnose Pneumocystis
This clinical capacity has allowed us to diagnose opportunistic pneumonias in the sickest HIV-infected individuals (median CD4 cell count = 67 cells/ul; >75%
with a CD4 cell count <200 cells/ul). It has allowed us to include LJ and MGIT cultures and Xpert testing and add to sputum (and BAL) smear microscopy to
diagnose 2,014 individuals with pulmonary TB.
We have trained physicians to perform bronchoscopy (hurray for Dr. Rejani!), trained nurses to perform assessment and monitoring and to assist during
bronchoscopy, and trained laboratory technicians in both standard microbiologic procedures as well as state-of-the-art research methods.
The MIND Study has provided the research infrastructure to allow both US and Uganda team members access to clinical data and specimens in order to obtain
advanced (Masters, PhD) degrees and to develop their own careers.
Finally, the MIND Study has allowed an incredible group of individuals – smart, hard-working, passionate and compassionate – to work together as a
multi-national team to meet our vision to be the leading clinical and translational research group studying HIV-associated pulmonary diseases in the US and internationally. Each day, we enthusiastically meet our mission to conduct the highest quality clinical and translational research – research that will improve the care of our patients and research that will advance our understanding of important lung diseases that affect our patients. We also wholeheartedly embrace our goal to provide the highest quality clinical care to the participants who are enrolled in our research studies and to work together in a collaborative and collegial environment where the contributions of each team member are valued.
Long Live the MIND Study!
Minutes for Uganda Malaria Surveillance Program (UMSP): Strategic Planning Retreat 12th-13th Jan 2017
Minutes for Uganda Malaria Surveillance Program (UMSP): Strategic Planning Retreat-12th-13th Jan 2017 Download Minutes.
2016 - 2017 Global Health Series Conferences
Keystone Symposia is very pleased to announce an expansion of it's Global Health Travel Award program funded by the Bill & Melinda Gates Foundation. Global Health Travel Awards, providing full funding for investigators from low- and middle-income countries, are now available for 11 meetings in the 2016-2017 meeting season. While application deadlines have passed for the first two meetings, they are still open for nine more, including the December 2016 conference on Hemorrhagic Fever Viruses. Below are these meetings and associated deadlines. In addition to the travel awards, scholarships of up to $1,200 are also available for graduate students and postdoctoral fellows.
Click here to learn more and apply.
The Fourth Global Symposium on Health Systems Research
The Fourth Global Symposium on Health Systems Research is taking place in Vancouver from 14-18 November 2016. Health Systems Global organizes a symposium every two years to bring together its members with the full range of players involved in health systems and policy research. There is currently no other international gathering that serves the needs of this community. Participants will include researchers, policy-makers, funders, implementers, civil society and other stakeholders from relevant national and regional associations and professional organizations. IDRC represented by Mr. Gilbert Asiimwe, who will be making a presentation on "A Comparative Analysis of GAVI and the Global Fund’s Approach to Health Systems Strengthening". This is part of our work on the GAVI Full Country Evaluation.
6th Annual ICEMR meeting
The 6th Annual International Centres of Excellence in Malaria Research (ICEMR) Networking meeting was held in Kampala at the Speke Resort Munyonyo from 15th to 17th August 2016. The purpose of the ICEMR workshop was to strengthen the collaboration among the 10 ICEMR centres by sharing expertise, experience, research findings among others.
Malaria Research to Policy Dissemination meeting
In an effort to reduce Malaria prevalence in the country, IDRC has undertaken a number of studies to guide the implementation of national malaria control interventions. The studies generate new scientific knowledge on disease determinants, diagnostics and approaches to combat disease with the objective of promoting evidence-based approach to policy making through our direct linkage with policy makers. On 18th August 2016, IDRC disseminated its research findings at Kampala Serena Hotel.